BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37842359)

  • 1. Comparison of Hamilton Depression Rating Scale and Montgomery-Åsberg Depression Rating Scale: Baked Straight From a Randomized Study.
    Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
    Cureus; 2023 Sep; 15(9):e45098. PubMed ID: 37842359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder.
    Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
    Cureus; 2023 Apr; 15(4):e37858. PubMed ID: 37213947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Controlled Trial Comparing Efficacy and Safety of Antidepressant Monotherapy.
    Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
    Cureus; 2024 Apr; 16(4):e59074. PubMed ID: 38800340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Effects of Antidepressants: Results of a Randomized Study's Interim Analysis.
    Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
    Cureus; 2023 Jul; 15(7):e42585. PubMed ID: 37641760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life and Medication Adherence in Patients With Major Depressive Disorder: An Interim Analysis of a Randomized Study.
    Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
    Cureus; 2023 Jun; 15(6):e39997. PubMed ID: 37415997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study.
    Kadam RL; Sontakke SD; Tiple P; Motghare VM; Bajait CS; Kalikar MV
    Indian J Pharmacol; 2020; 52(2):79-85. PubMed ID: 32565594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder.
    Khan A; Cutler AJ; Kajdasz DK; Gallipoli S; Athanasiou M; Robinson DS; Whalen H; Reed CR
    J Clin Psychiatry; 2011 Apr; 72(4):441-7. PubMed ID: 21527122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study.
    Woo YS; McIntyre RS; Kim JB; Lee MS; Kim JM; Yim HW; Jun TY
    Clin Psychopharmacol Neurosci; 2017 Nov; 15(4):391-401. PubMed ID: 29073751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Rickels K; Athanasiou M; Robinson DS; Gibertini M; Whalen H; Reed CR
    J Clin Psychiatry; 2009 Mar; 70(3):326-33. PubMed ID: 19284933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder.
    Sinha S; Chary S; Thakur P; Talluri L; Reddy M; Verma KK; Saha P; Gupta VB; Ramaiah KA; Khanum SZ
    Cureus; 2021 Jul; 13(7):e16689. PubMed ID: 34513348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder.
    Rele S; Millet R; Kim S; Paik JW; Kim S; Masand PS; Patkar AA
    Prim Care Companion CNS Disord; 2015; 17(4):. PubMed ID: 26693034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale.
    Ahmadpanah M; Sheikhbabaei M; Haghighi M; Roham F; Jahangard L; Akhondi A; Sadeghi Bahmani D; Bajoghli H; Holsboer-Trachsler E; Brand S
    Neuropsychiatr Dis Treat; 2016; 12():603-7. PubMed ID: 27022265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials.
    Hengartner MP; Jakobsen JC; Sørensen A; Plöderl M
    PLoS One; 2020; 15(2):e0229381. PubMed ID: 32101579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vortioxetine versus venlafaxine on cognitive functions in adults with major depressive disorder: A randomized-controlled trial.
    Manna CK; Ranjan R; Kumar P; Ahmad S; Nath S
    Indian J Psychiatry; 2023 Aug; 65(8):815-824. PubMed ID: 37736222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study.
    Jeong JH; Bahk WM; Woo YS; Lee KU; Kim DH; Kim MD; Kim W; Yang JC; Lee KH
    Neuropsychiatr Dis Treat; 2015; 11():2557-64. PubMed ID: 26504387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
    Heo M; Murphy CF; Meyers BS
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
    Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP
    CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.